LB-LR1109

LB-LR1109 · LG Chem

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LB-LR1109, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC [Phase 1]

See pricing